Intiva BioPharma Inc. — Form D
Intiva BioPharma Inc. of GLENDALE, CO, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-06. The offering totals $1.4M, of which $1.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-12-06
- Form: D
- Accession: 0001625288-17-000006
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.4M
- Amount sold: $1.4M
- Investors: 69
- Date of first sale: 2017-11-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-300229
Issuer
- Name: Intiva BioPharma Inc.
- CIK: 0001625288
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4340 E KENTUCKY AVE, GLENDALE, CO, 80246
- Phone: 3034957583
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Alain Bankier | Director | Lakewood, CO |
| Jeffrey Friedland | Director | Glendale, CO |
| Jeffrey Friedland | Executive Officer | Glendale, CO |
| Richard Greenberg | Director | Glendale, CO |
| Richard Greenberg | Executive Officer | Glendale, CO |
| Evan Wasoff | Executive Officer | Glendale, CO |
| Robert Goldfarb | Executive Officer | Glendale, CO |
Other filings by this issuer (1)
More